(4-Chlorophenyl)(4-fluorophenyl)methanol - CAS 2795-76-8
Catalog: |
BB055611 |
Product Name: |
(4-Chlorophenyl)(4-fluorophenyl)methanol |
CAS: |
2795-76-8 |
Synonyms: |
(4-Chlorophenyl)(4-fluorophenyl)methanol; (4-chlorophenyl)-(4-fluorophenyl)methanol |
IUPAC Name: | (4-chlorophenyl)-(4-fluorophenyl)methanol |
Description: | (4-Chlorophenyl)(4-fluorophenyl)methanol |
Molecular Weight: | 236.67 |
Molecular Formula: | C13H10ClFO |
Canonical SMILES: | C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)O)F |
InChI: | InChI=1S/C13H10ClFO/c14-11-5-1-9(2-6-11)13(16)10-3-7-12(15)8-4-10/h1-8,13,16H |
InChI Key: | JCIWCQYNVZQYRV-UHFFFAOYSA-N |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-10669272-B2 | Substituted naphthyridinone compounds useful as T cell activators | 20180627 |
US-2020109140-A1 | Substituted naphthyridinone compounds useful as t cell activators | 20180627 |
WO-2020006018-A1 | Substituted naphthyridinone compounds useful as t cell activators | 20180627 |
TW-202019924-A | Substituted naphthyridone compounds as T cell activators | 20180627 |
AU-2019291794-A1 | Substituted naphthyridinone compounds useful as T cell activators | 20180627 |
CN-112654621-A | Substituted naphthyridinone compounds useful as T cell activators | 20180627 |
EP-3814348-A1 | Substituted naphthyridinone compounds useful as t cell activators | 20180627 |
KR-20210024586-A | Substituted naphthyridinone compounds useful as T cell activators | 20180627 |
US-10954238-B1 | Substituted naphthyridinone compounds useful as T cell activators | 20180627 |
BR-112020026681-A2 | NAFTHYRIDINONE COMPOUNDS REPLACED USEFUL AS T-CELL ACTIVATORS | 20180627 |
PMID | Publication Date | Title | Journal |
4740 | 19750801 | [Clinical experiences with the benzodiazepine derivative bromazepam in acute agitation and excitement conditions in psychiatry] | Der Nervenarzt |
Complexity: | 208 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 236.0404208 |
Formal Charge: | 0 |
Heavy Atom Count: | 16 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 236.0404208 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 20.2Ų |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS